Cargando…
The serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndrome
Spot 14 (S14) protein is primarily expressed in adipogenic tissues. Compared to wild type, S14 knockout mice had better resistance to diet-induced obesity and glucose tolerance. However, the association between serum S14 level and metabolic variables in humans has never been investigated. The object...
Autores principales: | Chen, Yen-Ting, Tseng, Ping-Huei, Tseng, Fen-Yu, Chi, Yu-Chiao, Han, Der-Sheng, Yang, Wei-Shiung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375670/ https://www.ncbi.nlm.nih.gov/pubmed/30763384 http://dx.doi.org/10.1371/journal.pone.0212341 |
Ejemplares similares
-
Serum Spot 14 concentration is negatively associated with thyroid-stimulating hormone level
por: Chen, Yen-Ting, et al.
Publicado: (2016) -
Human serum RNase-L level is inversely associated with metabolic syndrome and age
por: Wang, Yi-Ting, et al.
Publicado: (2017) -
Serum Myostatin Is Reduced in Individuals with Metabolic Syndrome
por: Han, Der-Sheng, et al.
Publicado: (2014) -
Serum levels of fetuin-A are negatively associated with log transformation levels of thyroid-stimulating hormone in patients with hyperthyroidism or euthyroidism: An observational study at a medical center in Taiwan
por: Tseng, Fen-Yu, et al.
Publicado: (2018) -
Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves’ disease patients with hyperthyroidism or subjects with euthyroidism: A prospective observational study
por: Tseng, Fen-Yu, et al.
Publicado: (2019)